Skip to main content
OpenTrials

Clinical trial condition

Coagulation Protein Disorders

Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.

784 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Coagulation Protein Disorders trial results

Completed

A Study to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors

NCT03191799

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Royal Prince Alfred Hospital; Haematology Camperdown, New South Wales, Australia
  • Alfred Hospital Melbourne, Victoria, Australia
  • Fiona Stanley Hospital Murdoch, Western Australia, Australia
  • UZ Leuven Gasthuisberg Leuven, Belgium
View all 72 locations
View Trial Details
Completed

A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors

NCT02795767

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of Colorado Denver, Children's Hospital Aurora, Colorado, United States
  • Children'S Healthcare of Atlanta Atlanta, Georgia, United States
  • Rush Medical Center Chicago, Illinois, United States
View all 28 locations
View Trial Details
Completed

BAX 826 Dose-Escalation Safety Study

NCT02716194

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • UMHAT "Sv. Georgi", EAD Plovdiv, Bulgaria
  • Werlhof-Institut Hanover, Lower Saxony, Germany
  • Medizinische Hochschule Hannover Hanover, Lower Saxony, Germany
  • Vivantes Klinikum im Friedrichshain - Landsberger Allee Berlin, Germany
View all 28 locations
View Trial Details
Completed

BAX 855 PK-guided Dosing

NCT02585960

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arizona Hemophilia & Thrombosis Center, located within The University of Arizona Cancer Center Tucson, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 83 locations
View Trial Details
Completed

BAX 855 Pediatric Study

NCT02210091

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • University of Colorado Denver, Colorado, United States
  • University of Florida College of Medicine Gainesville, Florida, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 39 locations
View Trial Details
Completed

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

NCT01913405

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • University of Florida College of Medicine Gainesville, Florida, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
  • University of Louisville Louisville, Kentucky, United States
  • Children's Mercy Hospitals & Clinics Kansas City, Missouri, United States
View all 22 locations
View Trial Details
Completed

BAX 855 Continuation

NCT01945593

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • University of Colorado Aurora, Colorado, United States
  • University of Florida College of Medicine Gainesville, Florida, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 89 locations
View Trial Details
Completed

Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients

NCT00157157

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Phoenix, Arizona, United States
  • Little Rock, Arkansas, United States
  • Los Angeles, California, United States
  • Washington D.C., District of Columbia, United States
View all 35 locations
View Trial Details

Related conditions